Figure 3From: Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study Scattered plots of mRNA expression values (40-DCT) of different HER family members. a HER2 vs. HER3; b HER2 vs. HER4; c HER3 vs. EGFR; and d HER3 vs. HER4. CT cycle threshold, DCT delta CT.Back to article page